US5747334A
(en)
*
|
1990-02-15 |
1998-05-05 |
The University Of North Carolina At Chapel Hill |
Random peptide library
|
US5498538A
(en)
*
|
1990-02-15 |
1996-03-12 |
The University Of North Carolina At Chapel Hill |
Totally synthetic affinity reagents
|
US5962219A
(en)
*
|
1990-06-11 |
1999-10-05 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-selex
|
US5843701A
(en)
*
|
1990-08-02 |
1998-12-01 |
Nexstar Pharmaceticals, Inc. |
Systematic polypeptide evolution by reverse translation
|
DE4112440C1
(fr)
*
|
1991-04-16 |
1992-10-22 |
Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De |
|
US5795747A
(en)
*
|
1991-04-16 |
1998-08-18 |
Evotec Biosystems Gmbh |
Process for manufacturing new biopolymers
|
AU2313392A
(en)
*
|
1991-08-01 |
1993-03-02 |
University Research Corporation |
Systematic polypeptide evolution by reverse translation
|
US5783384A
(en)
*
|
1992-01-13 |
1998-07-21 |
President And Fellows Of Harvard College |
Selection of binding-molecules
|
US5643873A
(en)
*
|
1992-05-06 |
1997-07-01 |
Affymax Technologies N.V. |
Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
|
US5648458A
(en)
*
|
1992-05-06 |
1997-07-15 |
Affymax Technologies N.V. |
Peptides and compounds that bind to ELAM-1
|
US5728802A
(en)
*
|
1992-05-06 |
1998-03-17 |
Affymax Technologies N.V. |
Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
|
WO1994005812A1
(fr)
*
|
1992-09-02 |
1994-03-17 |
The Scripps Research Institute |
Systeme couple d'amplification et de traduction de polynucleotides isothermes
|
AU8124694A
(en)
*
|
1993-10-29 |
1995-05-22 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
US5922545A
(en)
*
|
1993-10-29 |
1999-07-13 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
US5525734A
(en)
*
|
1994-06-22 |
1996-06-11 |
Affymax Technologies N.V. |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
US5525735A
(en)
*
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
WO1996009411A1
(fr)
*
|
1994-09-21 |
1996-03-28 |
Cytogen Corporation |
Peptides de liaison d'antigenes (abtides) provenant de banques de peptides
|
US5885577A
(en)
*
|
1994-09-21 |
1999-03-23 |
Cytogen Corporation |
Antigen binding peptides (abtides) from peptide libraries
|
ATE235504T1
(de)
*
|
1994-12-30 |
2003-04-15 |
Chiron Corp |
Verfahren zur kontrollierten synthese von beliebigen peptidmischungen kodierende polynukleotidmischungen
|
US6341256B1
(en)
|
1995-03-31 |
2002-01-22 |
Curagen Corporation |
Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination
|
US20010053523A1
(en)
*
|
1995-06-02 |
2001-12-20 |
M&E Biotech A/S. |
Method for identification of biologically active peptides and nucleic acids
|
US6537776B1
(en)
|
1999-06-14 |
2003-03-25 |
Diversa Corporation |
Synthetic ligation reassembly in directed evolution
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
JP2000511050A
(ja)
*
|
1996-05-31 |
2000-08-29 |
メディジーン・アクチェンゲゼルシャフト |
機能性分子表面の生成、スクリーニング、および展開のための新規の合成タンパク質の構造の鋳型
|
US6875620B1
(en)
*
|
1996-10-31 |
2005-04-05 |
Agilent Technologies, Inc. |
Tiling process for constructing a chemical array
|
RU2233878C2
(ru)
|
1997-01-21 |
2004-08-10 |
Дзе Дженерал Хоспитал Корпорейшн |
Способ отбора желательного белка и нуклеиновой кислоты, средства для его осуществления
|
US8207093B2
(en)
|
1997-01-21 |
2012-06-26 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US6261804B1
(en)
*
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
GB9703369D0
(en)
*
|
1997-02-18 |
1997-04-09 |
Lindqvist Bjorn H |
Process
|
GB2338237B
(en)
*
|
1997-02-18 |
2001-02-28 |
Actinova Ltd |
In vitro peptide or protein expression library
|
JP4086325B2
(ja)
|
1997-04-23 |
2008-05-14 |
プリュックテュン,アンドレアス |
標的分子と相互作用する(ポリ)ペプチドをコードする核酸分子の同定方法
|
DK1801214T3
(da)
*
|
1997-07-07 |
2011-01-24 |
Medical Res Council |
In vitro sorteringsfremgangsmåde
|
WO1999005256A2
(fr)
*
|
1997-07-24 |
1999-02-04 |
President And Fellows Of Harvard College |
Procede de clonage de proteines secretees
|
US6927025B1
(en)
|
1997-09-03 |
2005-08-09 |
Biovation Limited |
Methods for protein screening
|
ATE311443T1
(de)
*
|
1997-09-03 |
2005-12-15 |
Biovation Ltd |
Methoden zur durchforstung (screenen) von proteinen
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
DK1068357T3
(da)
|
1998-03-30 |
2011-12-12 |
Northwest Biotherapeutics Inc |
Terapeutiske og diagnostiske anvendelser baseret på CXCR-4-genets rolle i tumorgenese
|
WO1999051773A1
(fr)
|
1998-04-03 |
1999-10-14 |
Phylos, Inc. |
Systemes de proteines adressables
|
US6440695B1
(en)
*
|
1998-04-17 |
2002-08-27 |
Whitehead Institute For Biomedical Research |
Method for producing diverse libraries of encoded polypeptides
|
US20030170820A1
(en)
*
|
1998-05-08 |
2003-09-11 |
Gregory Coia |
Continuous in- vitro evolution
|
US6562622B1
(en)
*
|
1998-05-08 |
2003-05-13 |
Diatech Pty, Ltd |
Continuous in vitro evolution
|
GB9810756D0
(en)
|
1998-05-19 |
1998-07-15 |
Angeletti P Ist Richerche Bio |
Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
|
WO2000001849A1
(fr)
*
|
1998-07-02 |
2000-01-13 |
Invitro Diagnostics, Inc. |
Procedes, compositions et dispositif de fabrication d'acides nucleiques presentant une affinite selective pour une molecule cible
|
US20040106110A1
(en)
*
|
1998-07-30 |
2004-06-03 |
Solexa, Ltd. |
Preparation of polynucleotide arrays
|
US20030022207A1
(en)
*
|
1998-10-16 |
2003-01-30 |
Solexa, Ltd. |
Arrayed polynucleotides and their use in genome analysis
|
US6787308B2
(en)
*
|
1998-07-30 |
2004-09-07 |
Solexa Ltd. |
Arrayed biomolecules and their use in sequencing
|
US20100130368A1
(en)
*
|
1998-07-30 |
2010-05-27 |
Shankar Balasubramanian |
Method and system for sequencing polynucleotides
|
US20040002101A1
(en)
*
|
1998-08-12 |
2004-01-01 |
Proteus S.A. |
Method and kit for discovering nucleic acids that encode desired functions
|
CA2334946A1
(fr)
*
|
1998-08-17 |
2000-02-24 |
Phylos, Inc. |
Methodes de production d'acides nucleiques prives de regions non traduites 3' et d'optimisation de la formation d'une fusion arn cellulaire-proteine
|
US6602685B1
(en)
|
1998-08-17 |
2003-08-05 |
Phylos, Inc. |
Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
|
US20060088846A1
(en)
|
1998-08-28 |
2006-04-27 |
Michele Pagano |
Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
|
US6416950B1
(en)
*
|
1998-12-02 |
2002-07-09 |
Phylos, Inc. |
DNA-protein fusions and uses thereof
|
US7883704B2
(en)
*
|
1999-03-25 |
2011-02-08 |
Abbott Gmbh & Co. Kg |
Methods for inhibiting the activity of the P40 subunit of human IL-12
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
KR20130105766A
(ko)
|
1999-03-25 |
2013-09-25 |
애보트 게엠베하 운트 콤파니 카게 |
사람 il-12에 결합하는 사람 항체 및 이의 제조방법
|
AU5269800A
(en)
|
1999-05-14 |
2000-12-05 |
Arbor Vita Corporation |
Molecular interactions in allergy cells
|
US6623926B1
(en)
|
1999-06-01 |
2003-09-23 |
Phylos, Inc. |
Methods for producing 5′-nucleic acid-protein conjugates
|
US20030091999A1
(en)
*
|
1999-10-01 |
2003-05-15 |
Zhongping Yu |
Compositions and methods for identifying polypeptides and nucleic acid molecules
|
US7022479B2
(en)
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
EP1250463B1
(fr)
|
2000-01-24 |
2006-04-05 |
Compound Therapeutics, Inc. |
Methodes de diagnostique multiplexees et sensibles destinees a l'analyse de proteines
|
ES2253358T3
(es)
*
|
2000-03-31 |
2006-06-01 |
Cambridge Antibody Technology Limited |
Mejoras en la visualizacion del ribosoma.
|
AU2001259063A1
(en)
|
2000-04-12 |
2001-10-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
EP1339746A2
(fr)
|
2000-08-18 |
2003-09-03 |
Dyax Corp. |
Polypeptides de liaison pour proteine stimulatrice des lymphocytes b (blys)
|
WO2002020565A2
(fr)
|
2000-09-08 |
2002-03-14 |
Universität Zürich |
Groupes de proteines a domaines de repetition comprenant des modules de repetition
|
JP4723713B2
(ja)
*
|
2000-09-25 |
2011-07-13 |
トヨタ自動車株式会社 |
mRNAの潜在的翻訳制御因子のスクリーニング方法
|
WO2004022006A2
(fr)
|
2002-09-09 |
2004-03-18 |
Arbor Vita Corporation |
Procede de diagnostic du cancer du col de l'uterus
|
US20040091509A1
(en)
*
|
2000-12-14 |
2004-05-13 |
Avon Products, Inc. |
Skin care composition that mediates cell to cell communication
|
KR100401296B1
(ko)
*
|
2000-12-27 |
2003-10-11 |
드림바이오젠 주식회사 |
수식물질에 의해 수식된 단백질 변이체 및 이것의 제조방법
|
JP4061043B2
(ja)
|
2000-12-28 |
2008-03-12 |
株式会社ポストゲノム研究所 |
invitro転写/翻訳系によるペプチド等の製造方法
|
ATE335754T1
(de)
|
2001-03-19 |
2006-09-15 |
Harvard College |
Entwicklung neuer molekularer funktionen
|
EP1249499A1
(fr)
*
|
2001-04-10 |
2002-10-16 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Méthode et dispositif pour la detérmination et la sélection d'intéractions molécule-molécule
|
DK1385864T3
(da)
|
2001-04-13 |
2010-08-16 |
Human Genome Sciences Inc |
Anti-VEGF-2-antistoffer
|
EP1401850A1
(fr)
|
2001-06-20 |
2004-03-31 |
Nuevolution A/S |
Derives nucleosidiques pour elaboration de bibliotheque combinatoire
|
WO2002103008A2
(fr)
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Molecules a matrice et procedes d'utilisation de ces dernieres
|
GB0115841D0
(en)
|
2001-06-28 |
2001-08-22 |
Medical Res Council |
Ligand
|
EP1440083B1
(fr)
|
2001-10-25 |
2013-01-02 |
Medical Research Council |
Molecules
|
GB0126887D0
(en)
*
|
2001-11-08 |
2002-01-02 |
Univ London |
Method for producing and identifying soluble protein domains
|
GB0127564D0
(en)
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
JP2005512578A
(ja)
*
|
2001-12-19 |
2005-05-12 |
ロシュ ダイアグノスティックス コーポレーション |
Pcrをベースとする高効率のポリペプチドスクリーニング
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
EP1470148B1
(fr)
|
2002-02-01 |
2012-07-18 |
Life Technologies Corporation |
Oligonucleotides double brin
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
US20030166282A1
(en)
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
WO2003072054A2
(fr)
*
|
2002-02-25 |
2003-09-04 |
Cabot Corporation |
Conception de ligand specifique destinee a la filtration et a la purification biomoleculaires pour la bioseparation
|
CN101006177B
(zh)
|
2002-03-15 |
2011-10-12 |
纽韦卢森公司 |
改善的用于合成模制分子的方法
|
WO2003087313A2
(fr)
|
2002-04-08 |
2003-10-23 |
Pioneer Hi-Bred International, Inc. |
Procedes d'amelioration de l'exsertion de la soie de mais lorsqu'elle est sujette a des agressions
|
DE60328979D1
(de)
|
2002-05-10 |
2009-10-08 |
Jackson H M Found Military Med |
Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum
|
US20100075423A1
(en)
*
|
2002-06-12 |
2010-03-25 |
Life Technologies Corporation |
Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
|
AU2003276666A1
(en)
*
|
2002-06-12 |
2003-12-31 |
Ambion, Inc. |
Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
|
US20040248094A1
(en)
*
|
2002-06-12 |
2004-12-09 |
Ford Lance P. |
Methods and compositions relating to labeled RNA molecules that reduce gene expression
|
US20060002935A1
(en)
|
2002-06-28 |
2006-01-05 |
Domantis Limited |
Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
US10730906B2
(en)
|
2002-08-01 |
2020-08-04 |
Nuevolutions A/S |
Multi-step synthesis of templated molecules
|
JP4657919B2
(ja)
|
2002-08-19 |
2011-03-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
進化する新しい分子機能
|
EP2385118A1
(fr)
|
2002-09-06 |
2011-11-09 |
Isogenica Limited |
Bibliothèque d'expression de peptide in vitro
|
WO2004028682A2
(fr)
|
2002-09-27 |
2004-04-08 |
Carlsberg A/S |
Matrice polymere a codage spatial
|
ES2640279T3
(es)
|
2002-10-30 |
2017-11-02 |
Nuevolution A/S |
Procedimiento para la síntesis de un complejo bifuncional
|
JP2006505271A
(ja)
*
|
2002-11-04 |
2006-02-16 |
アイコジェネックス コーポレイション |
膜結合前駆タンパク質の構造およびプロセシングを調節する物質の同定のための方法
|
JP2006505272A
(ja)
*
|
2002-11-04 |
2006-02-16 |
バイオアークティック ニューロサイエンス アーベー |
βアミロイド前駆体タンパク質の構造およびプロセシングを調節する薬剤の同定のための方法
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
US9121110B2
(en)
|
2002-12-19 |
2015-09-01 |
Nuevolution A/S |
Quasirandom structure and function guided synthesis methods
|
WO2004060791A1
(fr)
|
2003-01-07 |
2004-07-22 |
Ramot At Tel Aviv University Ltd. |
Nanostructures de peptides encapsulant une matiere etrangere ainsi que procede de fabrication correspondant
|
EP1590477B1
(fr)
|
2003-01-29 |
2009-07-29 |
454 Corporation |
PROCÉDÉ D'AMPLIFICATION ET DE SÉQUENçAGE D'ACIDES NUCLÉIQUES
|
WO2004074429A2
(fr)
|
2003-02-21 |
2004-09-02 |
Nuevolution A/S |
Procede de production d'une banque de deuxieme generation
|
DK2236606T3
(da)
|
2003-03-20 |
2014-02-10 |
Nuevolution As |
Kodning af små molekyler ved ligering
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
US8048627B2
(en)
|
2003-07-05 |
2011-11-01 |
The Johns Hopkins University |
Method and compositions for detection and enumeration of genetic variations
|
US7585815B2
(en)
*
|
2003-07-24 |
2009-09-08 |
Lawrence Livermore National Security, Llc |
High throughput protein production screening
|
US20120202710A1
(en)
|
2003-09-09 |
2012-08-09 |
Integrigen, Inc. |
Methods and compositions for generation of germline human antibody genes
|
DE602004023960D1
(de)
|
2003-09-18 |
2009-12-17 |
Nuevolution As |
Methode zur Gewinnung struktureller Informationen kodierter Moleküle und zur Selektion von Verbindungen
|
JP4917889B2
(ja)
*
|
2003-09-25 |
2012-04-18 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル.ピー. |
アミロイド関連疾患を処置するための組成物及びその使用方法
|
US7625707B2
(en)
*
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
US7972994B2
(en)
|
2003-12-17 |
2011-07-05 |
Glaxosmithkline Llc |
Methods for synthesis of encoded libraries
|
MXPA06006863A
(es)
|
2003-12-17 |
2006-09-04 |
Praecis Pharm Inc |
Metodo para la sintesis de bibliotecas codificadas.
|
EP1709084A4
(fr)
|
2003-12-23 |
2008-05-28 |
Nono Inc |
Polypeptides pour la modulation de la liaison des proteines du canal de recepteur de potentiel transitoire et proteines associees au recepteur de potentiel transitoire
|
DK1730277T3
(da)
|
2004-03-22 |
2010-03-01 |
Nuevolution As |
Kodning ved ligering under anvendelse af byggebloksoligonukleotider
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
EP3070174B1
(fr)
|
2004-05-11 |
2019-11-06 |
Ncardia AG |
Découverte de médicaments utilisant des cellules différentiées in vitro
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
EP1781310B1
(fr)
|
2004-08-02 |
2015-10-14 |
Ramot at Tel Aviv University Ltd. |
Articles de nanostructures a base de peptides et leur procede de formation
|
WO2006018850A2
(fr)
|
2004-08-19 |
2006-02-23 |
Tel Aviv University Future Technology Development L.P. |
Compositions et leurs methodes d'utilisation dans le traitement de maladies associees aux amyloides
|
US7294484B2
(en)
|
2004-08-27 |
2007-11-13 |
Wyeth Research Ireland Limited |
Production of polypeptides
|
TWI374935B
(en)
|
2004-08-27 |
2012-10-21 |
Pfizer Ireland Pharmaceuticals |
Production of α-abeta
|
US7300773B2
(en)
*
|
2004-08-27 |
2007-11-27 |
Wyeth Research Ireland Limited |
Production of TNFR-Ig
|
US7786086B2
(en)
*
|
2004-09-08 |
2010-08-31 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
CN101724071A
(zh)
|
2004-10-08 |
2010-06-09 |
杜门蒂斯有限公司 |
抗肿瘤坏死因子受体1的单域抗体及其使用方法
|
KR100730875B1
(ko)
|
2004-12-07 |
2007-06-20 |
가부시키가이샤 시마즈세이사쿠쇼 |
번역반응 촉진 dna 단편 및 그것을 사용한 무세포계단백질 합성방법
|
US20060142228A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Ambion, Inc. |
Methods and compositions concerning siRNA's as mediators of RNA interference
|
EP1863531A1
(fr)
|
2005-03-19 |
2007-12-12 |
Medical Research Council |
Ameliorations dans ou concernant le traitement et la prevention d'infections virales
|
JO3058B1
(ar)
|
2005-04-29 |
2017-03-15 |
Applied Molecular Evolution Inc |
الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
|
WO2006123445A1
(fr)
*
|
2005-05-18 |
2006-11-23 |
Kyoto University |
Procede permettant d’exprimer une proteine
|
HUE042561T2
(hu)
|
2005-06-30 |
2019-07-29 |
Janssen Biotech Inc |
Anti-IL-23-ellenanyagok, készítmények, eljárások és alkalmazások
|
CA2617539A1
(fr)
|
2005-07-01 |
2007-01-11 |
Washington University In St. Louis |
Anticorps des recepteurs de chimiokines phosphospecifiques
|
WO2007011722A2
(fr)
|
2005-07-15 |
2007-01-25 |
President And Fellows Of Harvard College |
Systeme de decouverte de reaction
|
US20070111237A1
(en)
*
|
2005-09-14 |
2007-05-17 |
Maurizio Zanetti |
Process for identifying antigenized antibodies using ribosome cell free expression system
|
WO2007043048A2
(fr)
*
|
2005-10-11 |
2007-04-19 |
Ramot At Tel Aviv University Ltd. |
Hydrogels auto-assembles et leurs procedes d'elaboration et d'utilisation
|
WO2007053358A2
(fr)
|
2005-10-28 |
2007-05-10 |
Praecis Pharmaceuticals, Inc. |
Procedes d'identification de composes etudies, par recours a des bibliotheques codees
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
SI2341140T1
(sl)
|
2005-12-01 |
2017-12-29 |
Nuevolution A/S |
Postopki encimskega kodiranja za učinkovito sintezo velikih knjižnic
|
ES2517420T3
(es)
|
2005-12-29 |
2014-11-03 |
Janssen Biotech, Inc. |
Anticuerpos anti-IL-23 humanos, composiciones, procedimientos y usos
|
CA2636855C
(fr)
|
2006-01-11 |
2016-09-27 |
Raindance Technologies, Inc. |
Dispositifs microfluidiques et leurs procedes d'utilisation dans la formation et le controle de nanoreacteurs
|
JP2009529915A
(ja)
|
2006-03-20 |
2009-08-27 |
ゾーマ テクノロジー リミテッド |
ガストリン物質に対して特異的なヒト抗体および方法
|
US7749957B2
(en)
|
2006-04-06 |
2010-07-06 |
E.I. Du Pont De Nemours And Company |
Clay-binding peptides and methods of use
|
EP3031918B1
(fr)
|
2006-05-11 |
2018-03-14 |
Raindance Technologies Inc. |
Dispositifs microfluidiques
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
WO2008005290A2
(fr)
|
2006-06-29 |
2008-01-10 |
The Trustees Of Columbia University In The City Of New York |
Procédés de test d'agents anti-thrombotiques
|
WO2008008348A2
(fr)
|
2006-07-11 |
2008-01-17 |
Arbor Vita Corporation |
Procédé et compositions pour traiter un accident cérébro-vasculaire accompagné de fièvre
|
WO2008021123A1
(fr)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Tensioactifs fluorocarbonés stabilisateurs d'émulsions
|
US9580515B2
(en)
|
2006-08-21 |
2017-02-28 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Neukinase, a downstream protein of neuregulin
|
CA2669084A1
(fr)
|
2006-11-10 |
2008-05-29 |
Massachusetts Institute Of Technology |
Modulateurs de pak
|
AU2007333635B2
(en)
|
2006-12-20 |
2014-02-20 |
Xoma (Us) Llc |
Treatment of IL-1-beta related diseases
|
CN104524567A
(zh)
*
|
2007-01-16 |
2015-04-22 |
阿布维公司 |
用于治疗银屑病的方法
|
WO2008097559A2
(fr)
|
2007-02-06 |
2008-08-14 |
Brandeis University |
Manipulation de fluides et de réactions dans des systèmes microfluidiques
|
WO2008121301A1
(fr)
|
2007-03-29 |
2008-10-09 |
Abbott Laboratories |
Anticorps anti-il-12 humains cristallins
|
WO2008130623A1
(fr)
|
2007-04-19 |
2008-10-30 |
Brandeis University |
Manipulation de fluides, composants fluidiques et réactions dans des systèmes microfluidiques
|
WO2009015063A2
(fr)
|
2007-07-23 |
2009-01-29 |
Centocor |
Procédés et compositions pour traiter des troubles associés à une fibrose en utilisant des antagonistes de l'il-17
|
US7951559B2
(en)
*
|
2007-07-25 |
2011-05-31 |
E.I. Du Pont De Nemours And Company |
Recombinant peptide production using a cross-linkable solubility tag
|
US7829311B2
(en)
|
2007-07-25 |
2010-11-09 |
E.I. Du Pont De Nemours And Company |
Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
|
US7678883B2
(en)
|
2007-07-25 |
2010-03-16 |
E.I. Du Pont De Nemours And Company |
Solubility tags for the expression and purification of bioactive peptides
|
US7794963B2
(en)
|
2007-11-02 |
2010-09-14 |
E.I. Du Pont De Nemours And Company |
Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
|
MX2010005565A
(es)
|
2007-11-20 |
2010-06-11 |
Pioneer Hi Bred Int |
Genes de señalizacion de etileno en maiz y su modulacion para mejor tolerancia al estres en plantas.
|
MX2010006823A
(es)
|
2007-12-20 |
2010-09-30 |
Xoma Technology Ltd |
Metodos para el tratamiento de la gota.
|
KR20100126515A
(ko)
|
2008-03-18 |
2010-12-01 |
아보트 러보러터리즈 |
건선의 치료방법
|
GB0806562D0
(en)
|
2008-04-10 |
2008-05-14 |
Fermentas Uab |
Production of nucleic acid
|
JP2010043063A
(ja)
|
2008-05-09 |
2010-02-25 |
Agency For Science Technology & Research |
川崎病の診断及び治療
|
EP2315629B1
(fr)
|
2008-07-18 |
2021-12-15 |
Bio-Rad Laboratories, Inc. |
Bibliothèque de gouttelettes
|
EP3629022A1
(fr)
|
2008-07-25 |
2020-04-01 |
Richard W. Wagner |
Procédés de criblage de protéines
|
KR20160116056A
(ko)
|
2008-08-14 |
2016-10-06 |
테바 파마슈티컬즈 오스트레일리아 피티와이 엘티디 |
항-il-12/il-23 항체
|
JP2012503982A
(ja)
*
|
2008-09-26 |
2012-02-16 |
ワイス・エルエルシー |
適合性ディスプレイベクター系
|
US20100113304A1
(en)
*
|
2008-09-26 |
2010-05-06 |
Wyeth |
Compatible display vector systems
|
AU2009308935B2
(en)
|
2008-10-31 |
2015-02-26 |
Janssen Biotech, Inc. |
Fibronectin type III domain based scaffold compositions, methods and uses
|
CA2742969A1
(fr)
|
2008-11-07 |
2010-05-14 |
Fabrus Llc |
Anticorps anti-dll4 et utilisations associees
|
US20100172862A1
(en)
*
|
2008-11-28 |
2010-07-08 |
Abbott Laboratories |
Stable antibody compositions and methods of stabilizing same
|
US20100158846A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Hair-binding peptides
|
US20100158837A1
(en)
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Iron oxide-binding peptides
|
US20100158822A1
(en)
|
2008-12-18 |
2010-06-24 |
E .I. Du Pont De Nemours And Company |
Peptides that bind to silica-coated particles
|
US8287845B2
(en)
*
|
2008-12-18 |
2012-10-16 |
E I Du Pont De Nemours And Company |
Hair-binding peptides
|
WO2010074783A1
(fr)
|
2008-12-23 |
2010-07-01 |
The Trustees Of Columbia University In The City Of New York |
Inhibiteurs de la phosphodiestérase et utilisations de ces derniers
|
EP2379076B1
(fr)
|
2008-12-23 |
2014-11-12 |
The Trustees of Columbia University in the City of New York |
Inhibiteurs de la phosphodiestérase et utilisations de ces derniers
|
CN102596992B
(zh)
|
2009-02-12 |
2015-09-09 |
詹森生物科技公司 |
基于ⅲ型纤连蛋白结构域的支架组合物、方法及用途
|
WO2010101818A1
(fr)
|
2009-03-02 |
2010-09-10 |
Pioneer Hi-Bred International, Inc. |
Activateurs transcriptionnels nac impliqués dans la tolérance aux stress abiotiques
|
WO2010111231A1
(fr)
|
2009-03-23 |
2010-09-30 |
Raindance Technologies, Inc. |
Manipulation de gouttelettes microfluidiques
|
US8481678B2
(en)
|
2009-03-30 |
2013-07-09 |
E I Du Pont De Nemours And Company |
Peptide-based tooth whitening reagents
|
JP2012522057A
(ja)
*
|
2009-03-30 |
2012-09-20 |
ジヨンソン・アンド・ジヨンソン・コンシユーマー・カンパニーズ・インコーポレーテツド |
化粧用剤の送達のためのペプチドに基づく系
|
US20110035843A1
(en)
|
2009-08-05 |
2011-02-10 |
Pioneer Hi-Bred International, Inc. |
Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
|
KR101161622B1
(ko)
*
|
2009-08-31 |
2012-07-04 |
헬릭스 주식회사 |
번역 효율 증진용 dna 단편 및 이를 포함하는 재조합 벡터
|
WO2011032148A1
(fr)
*
|
2009-09-14 |
2011-03-17 |
Abbott Laboratories |
Procédés de traitement du psoriasis
|
US9885711B2
(en)
|
2009-09-25 |
2018-02-06 |
Xoma Technology Ltd. |
Screening methods
|
US8926976B2
(en)
*
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
US10520500B2
(en)
|
2009-10-09 |
2019-12-31 |
Abdeslam El Harrak |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
DK2488867T3
(da)
*
|
2009-10-14 |
2020-11-09 |
Janssen Biotech Inc |
Fremgangsmåder til affinitetsmodning af antistoffer
|
US20110165648A1
(en)
|
2009-11-04 |
2011-07-07 |
Menno Van Lookeren Campagne |
Co-crystal structure of factor D and anti-factor D antibody
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
JP6093180B2
(ja)
|
2009-12-10 |
2017-03-08 |
トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク |
ヒストンアセチルトランスフェラーゼ活性化剤及びその使用
|
US10640457B2
(en)
|
2009-12-10 |
2020-05-05 |
The Trustees Of Columbia University In The City Of New York |
Histone acetyltransferase activators and uses thereof
|
EP2517025B1
(fr)
|
2009-12-23 |
2019-11-27 |
Bio-Rad Laboratories, Inc. |
Procédés pour réduire l'échange de molécules entre des gouttelettes
|
TW201129384A
(en)
|
2010-02-10 |
2011-09-01 |
Immunogen Inc |
CD20 antibodies and uses thereof
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
CA2789425C
(fr)
|
2010-02-12 |
2020-04-28 |
Raindance Technologies, Inc. |
Analyse numerique d'analyte comportant la correction d'erreur de polymerase
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
JP5863045B2
(ja)
|
2010-03-11 |
2016-02-16 |
国立研究開発法人理化学研究所 |
ポリペプチド配列の選択方法、並びに金属酸化物または含珪素化合物結合ペプチドおよびその利用
|
LT2558577T
(lt)
|
2010-04-16 |
2019-03-12 |
Nuevolution A/S |
Bifunkciniai kompleksai ir tokių kompleksų gamybos ir naudojimo būdai
|
KR101863033B1
(ko)
|
2010-04-30 |
2018-06-01 |
얀센 바이오테크 인코포레이티드 |
안정화된 파이브로넥틴 도메인 조성물, 방법 및 용도
|
WO2012022734A2
(fr)
|
2010-08-16 |
2012-02-23 |
Medimmune Limited |
Anticorps anti-icam-1 et procédés d'utilisation
|
CA2807607A1
(fr)
|
2010-08-20 |
2012-02-23 |
Wyeth Llc |
Culture cellulaire de cellules adaptees exemptes de facteur de croissance
|
US8987415B2
(en)
|
2010-09-07 |
2015-03-24 |
Technische Universitaet Muenchen |
Recombinant bacterial lipocalin blc and uses thereof
|
US9562897B2
(en)
|
2010-09-30 |
2017-02-07 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
US9198911B2
(en)
|
2010-11-02 |
2015-12-01 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating hair loss disorders
|
WO2012061537A2
(fr)
|
2010-11-02 |
2012-05-10 |
The Trustees Of Columbia University In The City Of New York |
Méthodes de traitement de troubles capillaires
|
CA2822621C
(fr)
|
2010-12-22 |
2020-12-15 |
The Trustees Of Columbia University In The City Of New York |
Modulateurs de l'histone acetyltransferase et leurs utilisations
|
DE102010056289A1
(de)
|
2010-12-24 |
2012-06-28 |
Geneart Ag |
Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
|
EP2673614B1
(fr)
|
2011-02-11 |
2018-08-01 |
Raindance Technologies, Inc. |
Procédé de formation de gouttelettes mélangées
|
US9150852B2
(en)
|
2011-02-18 |
2015-10-06 |
Raindance Technologies, Inc. |
Compositions and methods for molecular labeling
|
JP5948673B2
(ja)
|
2011-03-10 |
2016-07-06 |
ジーンフロンティア株式会社 |
リポ多糖混入量を低減した蛋白質合成用組成物、該組成物を用いた蛋白質製造方法
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
US20120301904A1
(en)
*
|
2011-04-26 |
2012-11-29 |
Prosetta Antiviral, Inc |
Multiprotein assemblies
|
WO2012161227A1
(fr)
|
2011-05-23 |
2012-11-29 |
独立行政法人理化学研究所 |
Construction d'acide nucléique, complexe acide nucléique-protéine et leur utilisation
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
EP2714970B1
(fr)
|
2011-06-02 |
2017-04-19 |
Raindance Technologies, Inc. |
Quantification d'enzyme
|
CN108424451B
(zh)
|
2011-06-03 |
2022-09-09 |
佐马技术有限公司 |
对TGF-β具有特异性的抗体
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
CA2857374A1
(fr)
|
2011-09-02 |
2013-03-07 |
The Trustees Of Columbia University In The City Of New York |
Inhibiteurs de camkii, ip3r, calcineurine, p38 et mk2/3 pour traiter des perturbations metaboliques de l'obesite
|
CN109265543B
(zh)
|
2011-09-19 |
2022-04-26 |
阿克松神经***科学公司 |
阿尔茨海默病中的tau蛋白介导病变的基于蛋白质的疗法和诊断
|
IL277891B2
(en)
|
2011-09-27 |
2024-01-01 |
Janssen Biotech Inc |
Protein scaffolds based on type III fibronectin repeats with alternative binding surfaces
|
EP2768944B2
(fr)
|
2011-10-21 |
2023-11-22 |
Pfizer Inc. |
Addition de fer pour améliorer la culture cellulaire
|
CA2853449A1
(fr)
|
2011-10-25 |
2013-05-02 |
Pioneer Hi-Bred International, Inc. |
Procedes pour modifier la composition d'une paroi cellulaire vegetale pour ameliorer la production de biocarburant et la digestibilite de l'ensilage
|
WO2013096516A1
(fr)
|
2011-12-19 |
2013-06-27 |
Xoma Technology Ltd. |
Méthodes de traitement de l'acné
|
HUE040127T2
(hu)
|
2012-03-29 |
2019-02-28 |
Univ Columbia |
Eljárások hajhullási rendellenességek kezelésére
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
DE18200782T1
(de)
|
2012-04-02 |
2021-10-21 |
Modernatx, Inc. |
Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
|
EP2657334B1
(fr)
|
2012-04-26 |
2016-07-06 |
GeneFrontier Corporation |
Procédé efficace pour afficher un multimère de protéine
|
ES2755104T3
(es)
|
2012-05-17 |
2020-04-21 |
Ra Pharmaceuticals Inc |
Inhibidores peptídicos y peptidomiméticos
|
GB201214029D0
(en)
*
|
2012-08-07 |
2012-09-19 |
Queen Mary & Westfield College |
method
|
US9695228B2
(en)
|
2012-11-21 |
2017-07-04 |
Janssen Biotech, Inc. |
EGFR and c-Met fibronectin type III domain binding molecules
|
HUE041499T2
(hu)
|
2012-11-21 |
2019-05-28 |
Janssen Biotech Inc |
Bispecifikus EGFR/C-MET-ellenanyagok
|
WO2014144767A1
(fr)
|
2013-03-15 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Purification d'arnm par échange d'ions
|
WO2014152507A2
(fr)
|
2013-03-15 |
2014-09-25 |
Pioneer Hi-Bred International, Inc. |
Modulation de l'expression d'acc désaminase
|
EP2971165A4
(fr)
|
2013-03-15 |
2016-11-23 |
Moderna Therapeutics Inc |
Elimination de fragments d'adn dans des procédés de production d'arnm
|
US11377470B2
(en)
|
2013-03-15 |
2022-07-05 |
Modernatx, Inc. |
Ribonucleic acid purification
|
WO2014152027A1
(fr)
*
|
2013-03-15 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Procédés de fabrication pour la production de transcrits d'arn
|
EP3971287A1
(fr)
|
2013-07-11 |
2022-03-23 |
ModernaTX, Inc. |
Compositions comprenant des polynucléotides synthétiques codant pour des protéines liées à crispr et des arnsg synthétiques et méthodes d'utilisation
|
US10385088B2
(en)
|
2013-10-02 |
2019-08-20 |
Modernatx, Inc. |
Polynucleotide molecules and uses thereof
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
AU2014334627B2
(en)
|
2013-10-14 |
2019-07-25 |
Janssen Biotech, Inc. |
Cysteine engineered fibronectin type III domain binding molecules
|
US9309314B2
(en)
|
2013-12-03 |
2016-04-12 |
Agency For Science, Technology And Research (A*Star) |
Polypeptides, nucleic acids and uses thereof
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
HRP20220748T1
(hr)
|
2013-12-24 |
2022-09-02 |
Janssen Pharmaceutica Nv |
Anti-vista antitijela i fragmenti
|
US11193176B2
(en)
|
2013-12-31 |
2021-12-07 |
Bio-Rad Laboratories, Inc. |
Method for detecting and quantifying latent retroviral RNA species
|
EP3119876A1
(fr)
|
2014-03-19 |
2017-01-25 |
Pfizer Inc. |
Procédé de culture cellulaire
|
NZ727420A
(en)
|
2014-06-12 |
2018-06-29 |
Ra Pharmaceuticals Inc |
Modulation of complement activity
|
WO2015196128A2
(fr)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Molécules d'acide nucléique alternatives et leurs utilisations
|
CN114057857A
(zh)
|
2014-06-20 |
2022-02-18 |
豪夫迈·罗氏有限公司 |
基于chagasin的支架组合物、方法和应用
|
JP2017522028A
(ja)
|
2014-07-16 |
2017-08-10 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
環状ポリヌクレオチド
|
PT3250230T
(pt)
|
2015-01-28 |
2021-12-07 |
Ra Pharmaceuticals Inc |
Moduladores da atividade do complemento
|
EP3265491A1
(fr)
|
2015-03-03 |
2018-01-10 |
Xoma (Us) Llc |
Traitement d'une hyperinsulinémie post-prandiale et d'une hypoglycémie après chirurgie bariatrique
|
CN108136001B
(zh)
|
2015-04-03 |
2022-07-29 |
佐马技术有限公司 |
使用TGF-β抑制剂和PD-1抑制剂治疗癌症
|
KR20240093813A
(ko)
|
2015-04-24 |
2024-06-24 |
제넨테크, 인크. |
다중특이적 항원-결합 단백질
|
KR102625793B1
(ko)
|
2015-05-06 |
2024-01-15 |
얀센 바이오테크 인코포레이티드 |
전립선 특이적 막 항원 결합 피브로넥틴 iii형 도메인
|
DK3313882T3
(da)
|
2015-06-24 |
2020-05-11 |
Janssen Pharmaceutica Nv |
Anti-VISTA antistoffer og fragmenter
|
US10253101B2
(en)
|
2015-08-06 |
2019-04-09 |
Xoma (Us) Llc |
Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
WO2017049286A1
(fr)
|
2015-09-17 |
2017-03-23 |
Moderna Therapeutics, Inc. |
Polynucléotides contenant un lieur morpholino
|
WO2017051347A2
(fr)
|
2015-09-23 |
2017-03-30 |
Pfizer Inc. |
Cellules et procédé de culture cellulaire
|
EP3389692B1
(fr)
|
2015-12-16 |
2020-03-04 |
RA Pharmaceuticals, Inc. |
Modulateurs de l'activité du complément
|
US10899836B2
(en)
|
2016-02-12 |
2021-01-26 |
Janssen Pharmaceutica Nv |
Method of identifying anti-VISTA antibodies
|
US10765724B2
(en)
|
2016-03-29 |
2020-09-08 |
Janssen Biotech, Inc. |
Method of treating psoriasis with increased interval dosing of anti-IL12/23 antibody
|
JP7253923B2
(ja)
|
2016-04-05 |
2023-04-07 |
ファイザー・インク |
細胞培養プロセス
|
WO2017175058A1
(fr)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anticorps anti-vista et fragments de ceux-ci, leurs utilisations et leurs procédés d'identification
|
MX2018014876A
(es)
|
2016-06-03 |
2019-05-22 |
Janssen Biotech Inc |
Dominios tipo iii de fibronectina de unión a albúmina sérica.
|
WO2017223180A2
(fr)
|
2016-06-21 |
2017-12-28 |
Janssen Biotech, Inc. |
Molécules de liaison au domaine de fibronectine de type iii modifiées par la cystéine
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
CA3028002A1
(fr)
|
2016-06-27 |
2018-01-04 |
Juno Therapeutics, Inc. |
Procede d'identification d'epitopes peptidiques, molecules qui se lient a de tels epitopes et utilisations associees
|
JP2019528044A
(ja)
|
2016-07-15 |
2019-10-10 |
ポセイダ セラピューティクス, インコーポレイテッド |
Muc1に特異的なキメラ抗原受容体(cars)およびその使用方法
|
BR112019000683A2
(pt)
|
2016-07-15 |
2019-04-24 |
Poseida Therapeutics Inc |
receptores de antígeno quiméricos e métodos para uso
|
CN109803680B
(zh)
|
2016-08-01 |
2024-05-17 |
佐马美国有限公司 |
甲状旁腺激素受体1(pth1r)抗体和其用途
|
JP7088932B2
(ja)
|
2016-09-14 |
2022-06-21 |
ヤンセン バイオテツク,インコーポレーテツド |
Bcma特異的フィブロネクチンiii型ドメインを有するキメラ抗原受容体、及びその使用
|
JP2019534710A
(ja)
|
2016-09-28 |
2019-12-05 |
ゾーマ (ユーエス) リミテッド ライアビリティ カンパニー |
インターロイキン2に結合する抗体およびその使用
|
CA3037961A1
(fr)
|
2016-09-30 |
2018-04-05 |
Janssen Biotech, Inc. |
Procede sur et efficace de traitement du psoriasis avec un anticorps specifique contre l'il-23
|
JP2020502261A
(ja)
|
2016-11-16 |
2020-01-23 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で乾癬を治療する方法
|
US11123399B2
(en)
|
2016-12-07 |
2021-09-21 |
Ra Pharmaceuticals, Inc. |
Modulators of complement activity
|
US10611823B2
(en)
|
2016-12-14 |
2020-04-07 |
Hanssen Biotech, Inc |
CD137 binding fibronectin type III domains
|
WO2018111976A1
(fr)
|
2016-12-14 |
2018-06-21 |
Janssen Biotech, Inc. |
Domaines de fibronectine de type iii se liant à pd-l1
|
BR112019012154A2
(pt)
|
2016-12-14 |
2019-11-12 |
Janssen Biotech Inc |
domínios do tipo iii da fibronectina de ligação a cd8a
|
EP3354736B1
(fr)
*
|
2017-01-25 |
2020-07-01 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Construction de promoteur pour synthèse de protéine acellulaire
|
KR20240038146A
(ko)
|
2017-01-30 |
2024-03-22 |
얀센 바이오테크 인코포레이티드 |
활성 건선성 관절염의 치료를 위한 항-tnf 항체, 조성물, 및 방법
|
CN110418652A
(zh)
|
2017-02-07 |
2019-11-05 |
詹森生物科技公司 |
用于治疗活动性强直性脊柱炎的抗tnf抗体、组合物和方法
|
CN110650743B
(zh)
|
2017-03-13 |
2023-12-29 |
波赛达治疗公司 |
用于选择性消除和替换造血干细胞的组合物和方法
|
CA3056182A1
(fr)
|
2017-03-16 |
2018-09-20 |
Pfizer Inc. |
Prototrophie a la tyrosine
|
JP2020532987A
(ja)
|
2017-09-08 |
2020-11-19 |
ポセイダ セラピューティクス,インコーポレイティド |
キメラリガンド受容体(clr)介在性の条件遺伝子発現のための組成物および方法
|
KR20200047702A
(ko)
|
2017-09-15 |
2020-05-07 |
브리스톨-마이어스 스큅 컴퍼니 |
관심 폴리펩티드 대규모 생산 동안의 온라인 바이오매스 정전용량 모니터링
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
WO2019150309A1
(fr)
|
2018-02-02 |
2019-08-08 |
Hammack Scott |
Modulateurs de gpr68 et leurs utilisations pour le traitement et la prévention de maladies
|
CA3092551A1
(fr)
|
2018-03-05 |
2019-09-12 |
Janssen Biotech, Inc. |
Methodes de traitement de la maladie de crohn avec un anticorps specifique anti-il23
|
WO2019178489A1
(fr)
|
2018-03-16 |
2019-09-19 |
Bristol-Myers Squibb Company |
Réduction de l'activité enzymatique métabolique et de la liaison disulfure lors de la production de protéines
|
JP2021523138A
(ja)
|
2018-05-11 |
2021-09-02 |
ヤンセン バイオテツク,インコーポレーテツド |
Il−23抗体を使用してうつを治療する方法
|
WO2020016838A2
(fr)
|
2018-07-18 |
2020-01-23 |
Janssen Biotech, Inc. |
Prédicteurs de réponse prolongée après le traitement avec un anticorps spécifique anti-il23
|
DK3883606T5
(da)
|
2018-09-24 |
2024-01-02 |
Janssen Biotech Inc |
Sikker og effektiv fremgangsmåde til behandling af colitis ulcerosa med anti-il12/il23-antistof
|
KR20210093973A
(ko)
|
2018-11-20 |
2021-07-28 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 건선을 치료하는 안전하고 효과적인 방법
|
US20220073942A1
(en)
|
2018-12-06 |
2022-03-10 |
Pfizer Inc. |
Cells with reduced inhibitor production and methods of use thereof
|
WO2020128864A1
(fr)
|
2018-12-18 |
2020-06-25 |
Janssen Biotech, Inc. |
Méthode sûre et efficace de traitement du lupus avec un anticorps anti-il12/il23
|
JP2022513507A
(ja)
|
2018-12-20 |
2022-02-08 |
ポセイダ セラピューティクス,インコーポレイティド |
ナノトランスポゾン組成物および使用方法
|
MX2021008537A
(es)
|
2019-01-15 |
2021-11-12 |
Janssen Biotech Inc |
Composiciones de anticuerpos anti-tnf y métodos para el tratamiento de la artritis idiopática juvenil.
|
KR20210118878A
(ko)
|
2019-01-23 |
2021-10-01 |
얀센 바이오테크 인코포레이티드 |
건선성 관절염의 치료 방법에 사용하기 위한 항-tnf 항체 조성물
|
EP3917571A4
(fr)
|
2019-01-31 |
2022-10-12 |
Agency For Science, Technology And Research |
Inhibiteur cnx/erp57 destiné à être utilisé dans le traitement ou la prévention du cancer
|
MA55282A
(fr)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech Inc |
Procédés de fabrication pour la production de compositions d'anticorps anti-tnf
|
EP3938384A4
(fr)
|
2019-03-14 |
2022-12-28 |
Janssen Biotech, Inc. |
Méthodes de fabrication permettant de produire des compositions d'anticorps anti-il12/il23
|
US20220153829A1
(en)
|
2019-03-14 |
2022-05-19 |
Janssen Biotech, Inc. |
Methods for Producing Anti-TNF Antibody Compositions
|
JP2022526881A
(ja)
|
2019-03-14 |
2022-05-27 |
ヤンセン バイオテツク,インコーポレーテツド |
抗tnf抗体組成物を産生するための方法
|
BR112021018441A2
(pt)
|
2019-03-18 |
2023-02-28 |
Janssen Biotech Inc |
Método para tratamento de psoríase em indivíduos pediátricos com anticorpo anti-il12/il23
|
EP3966244A1
(fr)
|
2019-05-09 |
2022-03-16 |
F. Hoffmann-La Roche AG |
Procédés de préparation d'anticorps
|
MX2021014302A
(es)
|
2019-05-23 |
2022-01-04 |
Janssen Biotech Inc |
Metodo para tratar la enfermedad inflamatoria del intestino con una terapia de combinacion de anticuerpos contra il-23 y tnf alfa.
|
CA3142580A1
(fr)
|
2019-06-03 |
2020-12-10 |
Janssen Biotech, Inc. |
Anticorps anti-tnf, compositions et methodes pour le traitement de la spondylarthrite ankylosante active
|
WO2020245676A1
(fr)
|
2019-06-03 |
2020-12-10 |
Janssen Biotech, Inc. |
Compositions d'anticorps anti-tnf et méthodes pour le traitement de l'arthrite psoriasique
|
WO2021028752A1
(fr)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anticorps anti-tfn pour le traitement du diabète de type i
|
CA3149892A1
(fr)
|
2019-09-05 |
2021-03-11 |
Eric M. Ostertag |
Compositions de cellules allogeniques et procedes d'utilisation
|
EP4045061A4
(fr)
|
2019-10-14 |
2024-04-17 |
ARO Biotherapeutics Company |
Domaines de type iii de fibronectine de liaison à cd137
|
WO2021076574A2
(fr)
|
2019-10-14 |
2021-04-22 |
Aro Biotherapeutics Company |
Conjugués domaine fn3-arnsi et leurs utilisations
|
US20230079955A1
(en)
|
2019-12-20 |
2023-03-16 |
Poseida Therapeutics, Inc. |
Anti-muc1 compositions and methods of use
|
EP4118107A1
(fr)
|
2020-03-11 |
2023-01-18 |
Poseida Therapeutics, Inc. |
Récepteurs stimulateurs chimériques et procédés d'utilisation dans l'activation et la différenciation de lymphocytes t
|
KR20230011295A
(ko)
|
2020-04-14 |
2023-01-20 |
포세이다 테라퓨틱스, 인크. |
암 치료에 사용하기 위한 조성물 및 방법
|
WO2022087148A1
(fr)
|
2020-10-21 |
2022-04-28 |
Poseida Therapeutics, Inc. |
Compositions et procédés d'administration d'acides nucléiques
|
US20220298236A1
(en)
|
2021-03-12 |
2022-09-22 |
Janssen Biotech, Inc. |
Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody
|
EP4305062A1
(fr)
|
2021-03-12 |
2024-01-17 |
Janssen Biotech, Inc. |
Méthode de traitement de patients souffrant de polyarthrite psoriasique ayant une réponse inadéquate à une thérapie par tnf avec un anticorps spécifique anti-il23
|
CN117916260A
(zh)
|
2021-07-09 |
2024-04-19 |
詹森生物科技公司 |
用于制备抗il12/il23抗体组合物的制造方法
|
AU2022306144A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
IL309996A
(en)
|
2021-07-09 |
2024-03-01 |
Janssen Biotech Inc |
Production methods for the production of anti-TNF antibody compositions
|
AU2022360244A1
(en)
|
2021-10-04 |
2024-04-11 |
Poseida Therapeutics, Inc. |
Transposon compositions and methods of use thereof
|
KR20240099352A
(ko)
|
2021-10-29 |
2024-06-28 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 크론병을 치료하는 방법
|
WO2023079058A1
(fr)
|
2021-11-05 |
2023-05-11 |
Yokogawa Insilico Biotechnology Gmbh |
Culture cellulaire avec production réduite de lactate
|
AU2022388887A1
(en)
|
2021-11-15 |
2024-07-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
US20230159633A1
(en)
|
2021-11-23 |
2023-05-25 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|
WO2023141576A1
(fr)
|
2022-01-21 |
2023-07-27 |
Poseida Therapeutics, Inc. |
Compositions et procédés d'administration d'acides nucléiques
|
WO2023148598A1
(fr)
|
2022-02-02 |
2023-08-10 |
Pfizer Inc. |
Prototrophie cystéinique
|
WO2023187707A1
(fr)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Méthode de traitement du psoriasis léger à modéré avec un anticorps spécifique d'il-23
|
WO2023223265A1
(fr)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Méthode d'évaluation et de traitement de l'arthrite psoriasique avec un anticorps il23
|
WO2024110898A1
(fr)
|
2022-11-22 |
2024-05-30 |
Janssen Biotech, Inc. |
Méthode de traitement de la rectocolite hémorragique avec un anticorps spécifique anti-il23
|